ArticleInternational journal of oncology2018

NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.

Yueyue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.